Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study
Background:. Aligning opioid prescribing with patient needs is important for managing pain while minimizing risks. However, little is known about opioid prescribing after gender-affirming procedures. Given that gender-diverse patients are at higher risk for poor opioid-related outcomes, creating gui...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-08-01
|
| Series: | Plastic and Reconstructive Surgery, Global Open |
| Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000007023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849222735222276096 |
|---|---|
| author | Kumaran Arivoli, BS Gabriela J. Kim, BS Brooke Kenney, MPH Caleb Haley, MD Megan Lane, MD, MS Christopher Breuler, MD Shane D. Morrison, MD, MS Jennifer Waljee, MD, MPH, MS Jessica J. Hsu, MD, PhD |
| author_facet | Kumaran Arivoli, BS Gabriela J. Kim, BS Brooke Kenney, MPH Caleb Haley, MD Megan Lane, MD, MS Christopher Breuler, MD Shane D. Morrison, MD, MS Jennifer Waljee, MD, MPH, MS Jessica J. Hsu, MD, PhD |
| author_sort | Kumaran Arivoli, BS |
| collection | DOAJ |
| description | Background:. Aligning opioid prescribing with patient needs is important for managing pain while minimizing risks. However, little is known about opioid prescribing after gender-affirming procedures. Given that gender-diverse patients are at higher risk for poor opioid-related outcomes, creating guidelines centered on patient-reported opioid use and pain experiences is critical. We conducted a prospective survey study examining opioid prescribing and consumption after gender-affirming mastectomy (GAM).
Methods:. Patients who underwent GAM from February to September 2021 were identified. Electronic medical record data were collected, including opioid prescription and refill amounts. Patient-reported outcomes including opioid use, nonopioid adjunct use, pain rating 1 week postoperatively, and pain management satisfaction were collected via telephone surveys 2–4 weeks postoperatively. Descriptive statistics and bivariate analyses compared outcomes between opioid consumers and nonconsumers.
Results:. Of 115 patients, 72 responded with complete data (62.6% response rate). Sixty-three individuals (87.5%) consumed opioids and 9 (12.5%) did not consume opioids. The median (interquartile range) opioid prescription quantity was 15 (12–17) tablets. The median (interquartile range) consumption was 10 (3–14.5) tablets (P < 0.001). Most patients (63.4%) felt their prescription amount was appropriate, whereas 28.2% said it was too much. In all, 94.4% used nonopioid adjuncts, and 100% were satisfied with their postoperative pain management.
Conclusions:. Most patients undergoing GAM reported using opioids, with an average of 10 pills, and were satisfied with their postoperative pain control. Going forward, surgeons should consider tailoring prescribing to patient needs and providing nonopioid alternatives when possible. |
| format | Article |
| id | doaj-art-2019004ad1fd41979ceca152c3300dea |
| institution | Kabale University |
| issn | 2169-7574 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Plastic and Reconstructive Surgery, Global Open |
| spelling | doaj-art-2019004ad1fd41979ceca152c3300dea2025-08-26T03:24:29ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742025-08-01138e702310.1097/GOX.0000000000007023202508000-00015Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey StudyKumaran Arivoli, BS0Gabriela J. Kim, BS1Brooke Kenney, MPH2Caleb Haley, MD3Megan Lane, MD, MS4Christopher Breuler, MD5Shane D. Morrison, MD, MS6Jennifer Waljee, MD, MPH, MS7Jessica J. Hsu, MD, PhD8From the * University of Michigan Medical School, Ann Arbor, MIFrom the * University of Michigan Medical School, Ann Arbor, MI† Michigan Opioid Prescribing Engagement Network, University of Michigan, Ann Arbor, MI‡ Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI‡ Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI‡ Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI§ Division of Plastic Surgery, Department of Surgery, University of Washington, Seattle, WA‡ Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI‡ Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MIBackground:. Aligning opioid prescribing with patient needs is important for managing pain while minimizing risks. However, little is known about opioid prescribing after gender-affirming procedures. Given that gender-diverse patients are at higher risk for poor opioid-related outcomes, creating guidelines centered on patient-reported opioid use and pain experiences is critical. We conducted a prospective survey study examining opioid prescribing and consumption after gender-affirming mastectomy (GAM). Methods:. Patients who underwent GAM from February to September 2021 were identified. Electronic medical record data were collected, including opioid prescription and refill amounts. Patient-reported outcomes including opioid use, nonopioid adjunct use, pain rating 1 week postoperatively, and pain management satisfaction were collected via telephone surveys 2–4 weeks postoperatively. Descriptive statistics and bivariate analyses compared outcomes between opioid consumers and nonconsumers. Results:. Of 115 patients, 72 responded with complete data (62.6% response rate). Sixty-three individuals (87.5%) consumed opioids and 9 (12.5%) did not consume opioids. The median (interquartile range) opioid prescription quantity was 15 (12–17) tablets. The median (interquartile range) consumption was 10 (3–14.5) tablets (P < 0.001). Most patients (63.4%) felt their prescription amount was appropriate, whereas 28.2% said it was too much. In all, 94.4% used nonopioid adjuncts, and 100% were satisfied with their postoperative pain management. Conclusions:. Most patients undergoing GAM reported using opioids, with an average of 10 pills, and were satisfied with their postoperative pain control. Going forward, surgeons should consider tailoring prescribing to patient needs and providing nonopioid alternatives when possible.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000007023 |
| spellingShingle | Kumaran Arivoli, BS Gabriela J. Kim, BS Brooke Kenney, MPH Caleb Haley, MD Megan Lane, MD, MS Christopher Breuler, MD Shane D. Morrison, MD, MS Jennifer Waljee, MD, MPH, MS Jessica J. Hsu, MD, PhD Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study Plastic and Reconstructive Surgery, Global Open |
| title | Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study |
| title_full | Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study |
| title_fullStr | Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study |
| title_full_unstemmed | Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study |
| title_short | Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study |
| title_sort | postoperative opioid prescription size and patient reported consumption following gender affirming mastectomy a prospective survey study |
| url | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000007023 |
| work_keys_str_mv | AT kumaranarivolibs postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT gabrielajkimbs postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT brookekenneymph postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT calebhaleymd postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT meganlanemdms postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT christopherbreulermd postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT shanedmorrisonmdms postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT jenniferwaljeemdmphms postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy AT jessicajhsumdphd postoperativeopioidprescriptionsizeandpatientreportedconsumptionfollowinggenderaffirmingmastectomyaprospectivesurveystudy |